Efficacy of Systane Balance to Stabilize the Tear Film in Dry Eye Subjects
Phase 4
Completed
- Conditions
- Dry Eye
- Interventions
- Other: Systane Ultra Lubricant Eye Drops
- Registration Number
- NCT01086774
- Lead Sponsor
- Alcon Research
- Brief Summary
Evaluation of the optical effects of Systane Ultra
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
- Age 18 years or more.
- Subjects must have Tear Break Up Time (TBUT) < 5 seconds
- Subjects must have a maximum blink interval (MBI) < 10 seconds
- Subjects must be willing to comply with all study requirements.
- Subjects must understand, sign and be given a copy of the written Informed Consent form.
Read More
Exclusion Criteria
- Subjects for whom both eyes do not meet all inclusion criteria and either eye meets exclusion criteria
- Subjects who are pregnant, lactating or planning to be pregnant during the course of the study
- Subjects with known sensitivity to planned study concomitant medications
- Subjects participating in any other ophthalmic drug or device clinical trial within 30 days of this clinical investigation.
- Use of ocular drugs, other than study medications, during the study and within 14 days prior to study entry or any other ocular medication
Read More
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Systane Ultra Systane Ultra Lubricant Eye Drops Systane Ultra Lubricant Eye Drops
- Primary Outcome Measures
Name Time Method Improvement in maximum blink interval (MBI) 1 day
- Secondary Outcome Measures
Name Time Method Tear film stability and contrast sensitivity 1 day